Menu Back toSession-3-GDPR-and-Data-Transparency-Requirements

Global Clinical Trials Transparency Conference


Session 3: GDPR and Data Transparency Requirements

Session Chair(s)

Merete  Joergensen, MBA, MSc

Merete Joergensen, MBA, MSc

  • Senior Trial Disclosure Director, Clinical Reporting Anchor & Disclosure
  • Novo Nordisk A/S, Denmark
How to ensure Data privacy and being Transparent at the same time gives rise to some considerations and concerns. What does this mean from a patient perspective, what are the considerations from industry trying to manoeuvre the requirements and what are the legal reality when working in this field.

Speaker(s)

David  Peloquin, JD

David Peloquin, JD

  • Senior Advisor, MRCT Center; Associate, Health care Group
  • Ropes & Gray LLP, United States
Deborah E. Collyar

Patient's perspectives on Data Privacy versus Data Transparency

Deborah E. Collyar

  • President
  • Patient Advocates In Research (PAIR), United States
Anne  Cutting

GDPR and Data Transparency: An Industry Perspective’

Anne Cutting

  • Director, Human Subject Research Governance
  • GSK, United Kingdom